LP
TBIO

LMR Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

LMR Partners’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-123,800
Closed -$2.04M – 1557
2021
Q1 		$2.04M Buy
+123,800
New +$2.82M 0.05% 322
2020
Q4 		– Sell
-187,600
Closed -$2.55M – 683
2020
Q3 		$2.55M Sell
187,600
-11,100
-6% -$171K 0.05% 136
2020
Q2 		$3.56M Buy
+198,700
New +$3M 0.09% 157

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LMR Partners's TBIO Position: Q2 2021 in Review

LMR Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 123,800 shares — an estimated $2.04M sold.

LMR Partners first reported a position in TBIO in Q2 2020 and held it in 3 quarters. The position peaked at $3.56M in Q2 2020. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • LMR Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • LMR Partners sold 123,800 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $2.04M.
  • LMR Partners first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • LMR Partners's Translate Bio, Inc. Common Stock position peaked at $3.56M in Q2 2020.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.